Rona Therapeutics raises $35M in series A+ to advance metabolic siRNA therapeutics 23-Jul-2024 By Clara Rodriguez Ferndandez The fundraising will support the development of the company’s technology platform for silencing RNA (siRNA), which has the potential to enable dosing patients every six months to treat a wide range of conditions.